Neuman Distributors recent acquisitions focus on independent pharmacy.
Executive Summary
NEUMAN BETTING ON INDEPENDENT PHARMACIES IN ACQUIRING DISEASE MANAGEMENT network Strategic Health Outcomes as part of a vertical and horizontal expansion strategy being pursued by the privately held Ridgefield, N.J.-based wholesaler. Neuman reported July 26 that it has purchased a "major stake" in SHO, a network of certified "disease-specific disease state management pharmacies" in New Jersey providing counseling for asthma and diabetes.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth